The hypocholesterolemic effects associated with soluble fi ber consumption are clear from animal model and human clinical investigations. Moreover, the modulation of whole-body cholesterol metabolism in response to dietary fi ber consumption, including intestinal cholesterol absorption and fecal sterol and bile acid loss, has been the subject of many published reports. However, our understanding of how dietary fi bers regulate molecular events at the gene/protein level and alter cellular cholesterol metabolism is limited. The modern emphasis on molecular nutrition and rapid progress in 'high-dimensional' biological techniques will permit further explorations of the role of genetic polymorphisms in determining the variable interindividual responses to soluble fi bers. Furthermore, with traditional molecular biology tools and the application of 'omic' technology, specifi c insight into how fi bers modulate the expression of genes and proteins that regulate intestinal cholesterol absorption and alter hepatic sterol balance will be gained. Detailed knowledge of the molecular mechanisms by which soluble fi bers reduce plasma cholesterol concentrations is paramount to developing novel fi ber-based "cocktails" that target specifi c metabolic pathways to gain maximal cholesterol reductions.
Introduction
Dietary fi ber may be considered the 'dinosaur' of functional foods. The hypolipidemic effects and cardioprotective benefi ts associated with dietary soluble fi ber consumption are abundantly clear from the results of human clinical trials (Anderson et al , 1991 (Anderson et al , 2000b Bell et al 1989; Braaten et al 1994; Naumann et al 2006) , animal feeding studies (van Bennekum et al 2005; Venkatesan et al 2007) , epidemiological investigations (Lairon et al 2005) , and meta-analysis reports (Ripsin et al 1992; Anderson et al 2000a; Anderson and Major 2002; Castro et al 2005) . Furthermore, the mechanisms by which soluble fi bers modulate cholesterol metabolism and effectively reduce circulating cholesterol concentrations have been the subject of many published reports (Fernandez et al 1999; Queenan et al 2007) . Such an extensive research history begs the question: Is the fi ber story over? Advancements in any biological discipline often require an assessment of current knowledge and a refl ection on what is not understood or has yet to be pursued. The objective of this review is to assess what is known regarding the role of soluble dietary fi ber in modulating cholesterol metabolism and reducing cardiovascular disease risk. To contextualize the place of fi ber in modern human health and disease prevention, we will begin with a brief account of the history of dietary fi ber research and the modern dietary fi ber classifi cation system. An additional objective of this review article is to explore what is known regarding the mechanisms by which fi ber consumption is thought to reduce plasma cholesterol concentrations. Finally, with the modern emphasis on molecular nutrition and the application of 'highdimensional biology' or 'omic' technology, we will review recent progress in understanding how fi ber consumption may regulate the enterohepatic metabolism of cholesterol at the molecular level and highlight current research priorities that will advance our existing knowledge base.
A brief history of dietary fi ber
In the mid 1970s, as the controversy surrounding the role of cholesterol in atherosclerosis reached an unparalleled point of contention within the medical community (Steinberg 2004 (Steinberg , 2005 , the dietary fi ber hypothesis emerged as the new paradigm of nutrition in human health and disease prevention. While modern dietary fi ber nutrition stemmed from observational and epidemiological studies in the 1970s, the hypothesis that the consumption of coarse foods of plant origin could modulate human health was not an entirely new concept. As early as 430 BC, Hippocrates understood the link between dietary fi ber and the 'diseases which befall a man' and recognized that 'to the human body it makes a great difference whether the bread be fi ne or coarse; of wheat with or without the hull' (Adams 1939) . Indeed, advances in the analysis (McCance et al 1936) and energy value (Atwater 1900 ) of these 'indigestible carbohydrates' had already been made by the 1930s. However, during the fi rst half of the 20th century, published reports on the functionality of dietary fi ber were few and the idea that a group of indigestible plant carbohydrates could facilitate disease prevention did not receive much attention from the nutritional community.
In the 1970s, several researchers including Burkitt (1972 ), Trowell (1972a ), Painter (1973 ), and Walker (1974 proposed that the low prevalence of cardiovascular diseases in developing countries was largely due to the consumption of a diet rich in fi ber. Following these initial observations, several early epidemiological investigations supported an inverse relationship between dietary fi ber consumption and the incidence of coronary heart disease (Morris et al 1977; Yano et al 1978; Kromhout et al 1982) .
One of the earliest researchers to provide experimental evidence in support of a protective role of dietary fi ber against coronary heart disease was David Kritchevsky. Kritchevsky was intrigued that saturated fat feeding induced atherosclerosis in rabbits fed semi-purifi ed diets, but not in chow-fed rabbits. Kritchevsky hypothesized that this discrepancy was likely due to the cardioprotective effects associated with dietary fi ber components in the commercial chow diets (Kritchevsky 1964) . The results from Kritchevsky's subsequent experiments supported his initial hypothesis of the cardioprotective effects of dietary fi bers (Kritchevsky and Tepper 1965, 1968) .
Although the dietary fi ber hypothesis gained acceptance, a comprehensive defi nition of dietary fi ber was needed in order to effectively study the epidemiological, physiological, and analytical aspects of these indigestible dietary components. However, the development of a comprehensive defi nition of dietary fi ber that satisfi ed the distinct considerations of nutritionists, food technologists, and food chemists became the subject of great debate. In 1972, Trowell originally defi ned dietary fi ber as 'the skeletal remains of plant cells that are resistant to hydrolysis of the enzymes of man' (Trowell 1972b ). This defi nition was restricted to plant cell wall components including cellulose, hemicellulose, lignin, and other minor components such as waxes and cutin. This defi nition was subsequently amended to include plant storage polysaccharides such as gums and pectins, that have similar biological effects of traditional cell wall components, but did not have their origin in structures other than the cell wall (Trowell 1976) .
With advances in analytical technology and a better understanding of the physiological implications of dietary fi ber, the American Association of Cereal Chemists (2001) proposed the following comprehensive defi nition: 'dietary fi ber is the edible parts of plants or analogous carbohydrates that are resistant to digestion and absorption in the human small intestine with complete or partial fermentation in the large intestine. Dietary fi ber includes polysaccharides, oligosaccharides, lignin, and associated plant substances. Dietary fi ber promotes benefi cial physiological effects including laxation, and/or blood cholesterol attenuation, and/or blood glucose attenuation'. Ha and colleagues (2000) have criticized physiological-based fi ber defi nitions that stress large intestinal fermentation without including possible interactions of dietary fi ber with other dietary components in the upper gastrointestinal tract.
More recently, the Joint FAO/WHO Expert Consultation on Carbohydrates in Human Nutrition (Mann et al 2007) conceded that a re-evaluation of the fi ber defi nition was warranted and proposed that dietary fi ber should be defi ned as 'intrinsic plant cell wall polysaccharides'.
Current understanding in fi ber nutrition Classifi cation of dietary fi ber
With years of research supporting the hypolipidemic effects and cardioprotective benefits associated with Dietary fi ber and cholesterol homeostasis fi ber consumption, recommendations for increased fi ber consumption from health authorities around the world are justifi ed (Heart and Stroke Foundation of Canada 2003; Lichtenstein et al 2006) . However, it is also clear that actual fi ber consumption in North America is much lower than what is currently recommended (James et al 2003) . This discrepancy may be due to the confusion created by the broad range of substances that are classifi ed under the umbrella of 'dietary fi ber' and the lack of knowledge concerning the effect of different fi bers on human health (Shamliyan et al 2006) . Dietary fi bers are typically classifi ed according to various physical-chemical and physiological criteria including solubility, viscosity, and fermentability (James et al 2003) . Generally, soluble fi bers such as guar gum (GG), pectin, and psyllium are highly viscous and are readily fermented to short-chain fatty acids (SCFA) in the large bowel in comparison with insoluble fi bers such as cellulose (James et al 2003) . Furthermore, soluble fi bers elicit a much more pronounced hypolipidemic and hypoglycemic response than their insoluble counterparts (Fernandez 2001) .
The variable hypocholesterolemic response to soluble fi ber consumption Consumption of water-soluble, viscous-forming fi bers such as GG, pectin, and psyllium has consistently been shown to reduce plasma cholesterol in human subjects (Brown et al 1999; Knopp et al 1999; Schneeman 1999; Butt et al 2007) . The extent of cholesterol lowering in response to fi ber consumption is variable, depending on a number of factors including the nature of the background diet, type of dietary fi ber, length of adaptation period, and amount of fi ber consumed. Furthermore, much of this variability in the plasma lipid-changes reported in response to dietary fi ber consumption is thought to have a genetic basis (Cara et al 1992) .
The greatest hypolipidemic effects in response to soluble fi ber consumption are seen in animal model investigations where experimental conditions allow fi ber intake to be above what is typically observed in humans. Fernandez and colleagues have reported a reduction in total plasma cholesterol up to 43% in guinea pigs fed a high cholesterol (0.25%) diet supplemented with 12.5% GG (Shen et al 1998) . Interestingly, the cholesterol-lowering effect of GG is more pronounced when consumed with a high-cholesterol diet compared with a cholesterol-free diet. In rats fed 7.5% GG, Moundras and colleagues (1997) reported total plasma cholesterol reductions of 14 and 32% with cholesterolfree or cholesterol-enriched (0.3%) diets, respectively. Similarly, guinea pigs fed diets supplemented with 12.5% GG responded with a 22% reduction in plasma total cholesterol on a low-cholesterol (0.04%) diet, but demonstrated a 38% reduction in total plasma cholesterol on a high-cholesterol diet (0.25%) (Fernandez 1995) .
Clinical investigations typically report low-density lipoprotein (LDL)-cholesterol reductions in the range of 6%-15% (Fernandez 2001) . Following the consumption of 14 g/d of psyllium in twenty type 2 diabetic patients for 6 weeks, Sierra and colleagues (2002) observed a reduction in total and LDL-cholesterol by 7% and 9%, respectively. In addition, a large reduction (25%) in LDL-cholesterol was observed in 24 healthy volunteers receiving 9 g of GG per day for 4 weeks (Khan et al 1981) . Alternatively, a meta analysis of 67 controlled studies by Brown and colleagues (1999) suggested that consumption of 2-10 g of major dietary fi bers such as pectin, oat bran, guar gum and psyllium resulted in small but signifi cant reductions in total and LDL-cholesterol. Finally, postprandial circulating lipid concentrations have also been shown to shift favorably following the consumption of dietary fi ber. Consumption of a high fi ber test meal with 15.7 g of beta-glucan reduced postprandial cholesterol concentrations below the fasting level in 11 healthy men in comparison to a low fi ber test meal with 5.0 g of beta-glucan (Bourdon et al 1999) .
Cholesterol-lowering mechanisms of soluble fi bers
Our traditional understanding of how dietary soluble fi bers alter cholesterol metabolism and reduce circulating cholesterol concentrations is illustrated in Figure 1 . It is widely accepted that soluble fi bers act primarily in the intestine to promote secondary responses in the liver and peripheral circulation from direct effects within the intestinal lumen (Fernandez et al 1997; Schneeman 1999) . One of the primary actions of soluble fi bers in the intestine is to reduce dietary fat and cholesterol uptake (Schneeman 1999) . Reductions in apparent intestinal cholesterol absorption have been reported in both human subjects (Simons et al 1982) and animal models (Levrat-Verny et al 2000) . Furthermore, in vitro cholesterol uptake into everted sacs of rat proximal small intestine from a solution of micelles was reduced by 40% when GG was included in the incubation medium (Gee et al 1983) . It has been proposed that the viscosity associated with soluble fi bers interferes with key physiological events in the cholesterol absorptive process. These interference mechanisms include direct binding of cholesterol within the intestinal lumen (Andersson 1992) , interference with the diffusion of luminal cholesterol toward the epithelial cell surface (Schneeman 1999) , and/or antagonization of the cholesterol emulsifi cation process (Minekus et al 2005) . While our knowledge concerning the molecular mechanisms responsible for cholesterol balance within intestinal enterocytes has greatly advanced in recent years, the reduction in cholesterol absorption in response to soluble fi ber consumption is most often attributed to viscosity with very little emphasis on the potential regulation of proteins that mediate intestinal cholesterol absorption (Dikeman and Fahey 2006) .
The hypocholesterolemic effects of soluble fi bers are also believed to result from an interference with the enterohepatic circulation of bile acids (Fernandez 2001) . Marlett and colleagues (1994) concluded that the consumption of oat bran in normolipidemic young men decreased serum cholesterol by altering the composition of the enterohepatic bile acid pool and increasing the fecal loss of total bile acids. These observations were further demonstrated in human clinical studies by Lia and colleagues (1995) , Andersson and colleagues (2002) , and Ellegård and Andersson (2007) . The dietary supplementation of psyllium at a level of 10% is associated with a dose-dependent increase in fecal bile acid excretion in rats (Buhman et al 2000) . Similarly, native amylo-maize resistant starch, a modifi ed starch with similar physiological effects to soluble fi bers, has been shown to increase the fecal excretion of primary bile acids in human subjects (van Munster et al 1994) . Interestingly, while GG was traditionally thought to reduce intestinal bile acid uptake, a series of reports in the late 1990's suggest that intestinal bile acid fl ux to the liver may actually be increased in response to GG consumption (Favier et al 1998; Moundras et al 1997; Moriceau et al 2000) . Therefore, the traditional mechanisms by which GG reduces plasma cholesterol concentrations may have to be re-evaluated.
The reduction in intestinal cholesterol absorption and bile acid uptake in response to soluble fi ber consumption are believed to alter hepatic cholesterol homeostasis by effectively reducing cholesterol concentrations in the liver by two related mechanisms. Firstly, a decrease in the delivery of dietary cholesterol to the liver through chylomicron remnants results in a direct reduction in the hepatic cholesterol pool (Fernandez 2001 Abbreviations: ABCG5/G8, ATP-binding cassette transporter G5 and G8; C, cholesterol; CE, cholesteryl ester; CYP7A, cholesterol 7a-hydroxylase; GG, guar gum; LDLr, low-density lipoprotein receptor; NPC1L1, Niemann-Pick-C-1 like 1; SCFA, short-chain fatty acids; SREBP2, sterol regulatory element binding protein 2.
12.5% has been shown to reduce hepatic free and esterifi ed cholesterol levels by 21% and 16%, respectively, in guinea pigs (Fernandez 1995) . Secondly, an increase in the fecal loss of bile acids and a reduction in the enterohepatic bile acid pool size may stimulate the liver to produce more bile acids from cholesterol, thus reducing hepatic free cholesterol concentrations (van Bennekum et al 2005) .
The increased hepatic demand for cholesterol from the fi ber-induced reduction in hepatic microsomal free cholesterol pool can be met by increasing the uptake of lipoprotein cholesterol from the plasma, the release of free cholesterol from intracellular storage of cholesteryl ester and membrane cholesterol, or by increasing hepatic cholesterol synthesis (Fernandez 2001; Rideout et al 2007) . Consumption of various types of soluble fi bers has been shown to increase the fractional catabolic rate of LDL (Vergara-Jimenez et al 1998) and hepatic LDLr expression (Fernandez 1995; Fukishima et al 2001; Han et al 2004) .
A compensatory increase in the expression of hepatic HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, is thought to account for the reduction in the hepatic free cholesterol pool following the consumption of GG (Favier et al 1998) , manufactured soluble fi ber from wood chips (Chai et al 2003) , psyllium (Buhman et al 2000) , and pectin (Garcia-Diez et al 1996) . It has been suggested that GG elicits a hypocholesterolemic effect even in the face of an increase in hepatic cholesterol synthesis, as the increase in HMG-CoAr activity is not suffi cient to compensate for fecal steroid loss in rats fed a diet supplemented with 7.5% GG (Moundras et al 1997) .
The reduction in hepatic free cholesterol concentrations following soluble fi ber consumption is thought to lead to a modifi cation of hepatic lipoprotein metabolism. Soluble fi ber consumption has been associated with a reduction in hepatic apolipoprotein B secretion and the formation of large triglyceride-rich, cholesteryl-ester-depleted very LDL (VLDL) particles (Fernandez 2001 ). This change in the endogenous cholesterol pathway results in a VLDL particle that is less prone to IDL and LDL conversion via extrahepatic lipases and LDL particles with a high peak density (Roy et al 2000; Fernandez 2001 ).
The production of SCFA by bacterial fermentation in the large intestine is thought to have multiple health benefi ts and may be involved in mediating the hypocholesterolemic effects of dietary fi ber (Chen et al 1984) . Furthermore, dietary fi bers with unique physiochemical properties elicit differential SCFA profi les in the large intestine . Strong evidence for this SCFA-induced hypocholesterolemic effect from fi ber fermentation comes from the observation that the cholesterol-lowering action of beet pulp disappears in rats following the removal of the cecum, both the cecum and colon, but not upon the removal of the colon alone (Nishimura et al 1993) . However, the reduction in total cholesterol, LDL-cholesterol, and apolipoprotein B concentrations in ileostomy subjects fed an oat bran based high fi ber diet suggests that large intestinal fi ber fermentation is not necessary for cholesterol-reductions in human subjects (Zhang et al 1992) . Particular emphasis has been placed on the role of butyrate as a signaling molecule that is important in regulating intestinal function and systemic cholesterol metabolism (Marcil et al 2002) . Moreover, it has recently been suggested that butyrate may impair the assembly of triglyceride-rich lipoproteins within intestinal enterocytes, as a decrease in the basolateral effl ux of cholesteryl ester in response to butyrate has been demonstrated in Caco-2 cells (Marcil et al 2003) .
Research priorities in dietary fi ber and cholesterol metabolism Individual physiological responses to dietary fi bers
The future of functional foods in modulating human health is closely connected to the concept of 'personalized nutrition' (Vakili and Caudill 2007) . The ability to specifi cally tailor dietary treatment based on individual genetic polymorphisms will bolster the importance of the diet in disease prevention and potentially revolutionize the world's health care system. Although dietary factors are effective modulators of cellular metabolism at the molecular level, it is becoming increasingly clear that there is considerable variability in the response of plasma lipids to various nutritional lipid-lowering therapies including plant sterols (Jones et al 1999) and dietary fi bers (Cara et al 1992) . This variable inter-individual response is in part due to single base variations within gene sequences that function as molecular targets of dietary bioactive components (Trujillo et al 2006) . Although the infl uence of genetic polymorphisms on the lipoprotein profi le in response to plant sterols (Plat and Mensink 2002) , dietary cholesterol (Robitaille et al 2007) , and soy isofl avones (Hall et al 2006) have been extensively studied, the role of genotype in determining the hypocholesterolemic effects of dietary fi bers has been the subject of few investigations.
Apolipoprotein E (ApoE), the major apoprotein component of chylomicrons, is polymorphic and thought to infl uence the response of plasma lipids to dietary intervention strategies (Zannis 1986 ). Jenkins' group has addressed the association between gene polymorphisms and the lipidlowering response to dietary fi ber consumption in three separate publications. In the fi rst of these publications, Jenkins and colleagues (1993) examined the association between the three common apo E alleles (E2, E3, and E4) and the plasma cholesterol response observed in 67 volunteers who completed a controlled dietary intervention that included a 2 week consumption of oat bran or wheat bran at a level of 6.8 g fi ber/1000 kcal. Total cholesterol, LDL-cholesterol, and apolipoprotein B (ApoB) concentrations were signifi cantly lower in subjects heterozygous for the E2 allele following fi ber consumption in comparison to the E3 homozygotes and E4 carriers. However, a more recent study by Wu and colleagues (2007) , using 22,915 free-living participants from the European Prospective Investigation of Cancer Norfolk study, suggest that ApoE genotype does not refl ect changes in plasma cholesterol profi le in response to dietary fat or fi ber intake. The authors propose that the apparent controversy surrounding the role of ApoE phenotypes in the serum lipid response to diet is likely due to the lack of statistical power associated with the small sample size used as part of the experimental design in previous investigations. In a second study from the Jenkins lab, Hegele and colleagues (1993) hypothesized that polymorphisms in genes regulating ApoB metabolism, including the low-density lipoprotein receptor (LDLr), ApoB, apolipoprotein CIII (ApoCIII), and hepatic lipase, could infl uence the fi ber-related reduction of ApoB containing lipoproteins. The results of this investigation suggested that LDLr genotype had a signifi cant impact on the plasma lipid response following dietary fi ber consumption. Finally, a preliminary investigation by Hegele and colleagues (1997) suggested that genetic variations in the fatty acid binding protein 2 gene, involved in regulating intestinal fatty acid absorption and intracellular transport (Hanhoff et al 2002) , may be involved in modulating the reductions in plasma cholesterol in response to dietary fi ber consumption. However, the authors suggest that the results be interpreted with caution due to the small sample size (n = 43) and the marginality associated with some of the statistical outcomes.
As can be seen from the above discussion, published reports on the role of gene polymorphism in the cholesterol-lowering response to soluble fi bers are few and often limited by small sample size. The hypocholesterolemic effects of dietary fi bers are initiated by primary intestinal events related to the digestion and absorption of dietary fat and cholesterol (Lairon 1996) . Therefore, investigation into the association between polymorphisms in genes that regulate intestinal triglyceride and cholesterol digestion and plasma lipoprotein outcomes in response to soluble fi ber consumption may be prudent. Indeed, pancreatic triglyceride lipase and carboxyl ester lipase, two enzymes involved in intestinal triglyceride and cholesterol digestion, have been shown to be highly polymorphic and may therefore explain some of the variability associated with dietary fiber consumption (Lidberge et al 1992; Cao and Hegele 2003) .
The 'omics' approach to dietary fi ber research
The focus of modern day nutrition research is shifting with the advent of novel, high-throughput investigative tools that permit an examination of how nutrients affect the global expression and characterization of transcripts, proteins, and metabolites (Afman and Muller 2006) . The application of multiplexing technology involved in nutrigenomics, nutriepigenetics, transcriptomics, proteomics, and metabolomics will advance our understanding of nutrient-gene-metabolite interactions and ultimately lead to the identifi cation of novel biomarkers of disease risk and the development of effective functional food products (Trujillo et al 2006) . Although this 'omics' approach to nutrition may currently be limited by its high expense and the need for highly qualifi ed individuals to analyze and integrate the vast amount of data that are generated, it has given us valuable insight into how the consumption of various dietary ingredients, including dietary fat (Kim et al 2004) , soy isofl avones (Fuchs et al 2007b) , dietary zinc (Blanchard et al 2001) , and plant sterols (Calpe-Berdiel et al 2007), affect global gene expression and cell metabolism. However, very few published reports have applied 'omic' technology to the dietary fi ber fi eld. One exception has been a recently published report by Fuchs and colleagues (2007a) who applied a proteomic approach to study the effect of fl axseed consumption on differentially expressed genes in human peripheral blood mononuclear cells. Flaxseed consumption at a level of 0.4 g/kg BW for 7 days, resulted in 16 differentially expressed proteins compared with the control group. This differential protein expression pattern included enhanced levels of peroxiredoxin and reduced expression of long-chain fatty acid β-oxidation multienzyme complex and glycoprotein IIIa/II, suggestive of an antithrombotic and antiinfl ammatory effect from the fl axseed treatment. Microarray technology has also been employed to study the mechanisms by which intestinal SCFA produced from fi ber fermentation in the large intestine affect the progression of colon cancers (Mariadason et al 2000; Daly et al 2006) . Given the heterogeneity associated with dietary fi bers, it is likely that fi ber Dietary fi ber and cholesterol homeostasis sources with different physiochemical properties will produce a unique metabolic 'footprint'. Furthermore, the movement of nutrition research from a reductionist science to a systems biology approach will allow the integration of complex biological information at the gene, protein, and metabolite level and advance our understanding of the role of dietary soluble fi ber in achieving optimal personalized health.
Regulation of genes and protein expression within the enterohepatic loop
In order to avoid the potential atherogenic consequences associated with elevated plasma cholesterol, elaborate regulatory mechanisms have evolved to balance the intestinal absorption and de novo synthesis of cholesterol (the major input pathways) with biliary cholesterol and bile acid excretion (the major output pathways) (Lammert and Wang 2005) . Our understanding of the molecular regulators of enterohepatic cholesterol and bile acid metabolism has been greatly advanced through the characterization of the major proteins involved in maintaining sterol balance at the intestinal and hepatic levels (Figure 2) . Within the intestine, cholesterol absorption and effl ux appear to be regulated largely through the brush-border membrane proteins Niemann-Pick C like 1 and ATP-binding cassette G5 and G8, respectively (Kruit et al 2006) . At the hepatic level, the clearance of plasma LDL and HDL-cholesterol occurs through the LDLr and the scavenger receptor class B, type 1 (SR-B1) while cholesterol synthesis and oxidation is precisely controlled through activity of the rate-limiting enzymes HMG-CoAr and cholesterol 7α-hydroxylase (CYP7A1), respectively (Dietschy et al 1993) . Furthermore, the infl uence of hepatic ABCG5/G8 expression on biliary cholesterol secretion and intestinal cholesterol absorption has only recently been recognized (Wu et al 2004; Rideout and Fan 2008) . Finally, numerous nuclear receptors (eg, LXR, FXR) and transcription factors (eg, SREBP2) have been shown to be critical in modulating transcriptional events and maintaining cholesterol homeostasis within the enterohepatic loop (Wong et al 2006) . Information concerning the effect of dietary fiber consumption on the expression of genes that regulate intestinal cholesterol absorption and hepatic sterol balance is limited. For the most part, published reports on the molecular mechanisms associated with the hypocholesterolemic effects of dietary fi bers have pertained to the hepatic mRNA expression of HMG-CoAr and CYP7A1 (Horton et al 1994; Kishida et al 2002; Han et al 2004) . Although these studies have provided insight into how fi bers may affect metabolism at the gene level, the expression of a gene from DNA to protein is a complex process with control mechanisms that regulate multiple steps including transcription rate, nuclear export and mRNA localization, transcript stability, translational effi ciency, protein degradation, and post-translational processing (Pradet-Balade et al 2001; Hanash and Beretta 2002; Yang et al 2008) . Therefore, cellular mRNA levels are often unreliable indicators of protein abundances, and the abundance of any particular protein does not necessarily reflect its catalytic activity (Hanash and Beretta 2002) . In an effort to more fully characterize the hypocholesterolemic effects of soluble fi ber at the molecular level, our recent work proposes several novel mechanisms by which GG may exert its effects. Firstly, our data suggests that the hypocholesterolemic effects of GG consumption are mediated by a reduction in hepatic free-cholesterol concentration and an associated SREBP2-dependent increase in hepatic LDLr mRNA and protein expression . At the transcriptional level, hepatic cholesterol metabolism is tightly controlled through SREBP2, a nuclear receptor that binds to sterol response elements in the promoter region of a multitude of target genes (Hua et al 1993) . In the absence of a change in SREBP2 mRNA, we observed an increase in the cytoplasmic precursor and nuclear active forms of SREBP2 without a corresponding increase in the cytoplasmic mature form of the protein in response to GG consumption. This differential expression pattern suggests GG consumption may have increased nuclear SREBP2 expression through mechanisms independent of protease-dependent cleavage at the Golgi.
Secondly, in response to GG consumption we observed an increase in hepatic ABCG5/G8 mRNA and protein expression and biliary cholesterol concentration in comparison to the control-fed pigs (Rideout 2007; Rideout and Fan 2008) . Traditionally, by interfering with the enterohepatic circulation and intestinal uptake of bile acids, soluble fi ber consumption is believed to modulate whole-body cholesterol excretion through stimulation of cholesterol catabolism to bile acids (Trautwein et al 1998) . However, an additional quantitatively important route of cholesterol excretion occurs through the biliary secretion and eventual fecal loss of free cholesterol (Spritz et al 1965) . Our recent data suggest that the stimulation of biliary free cholesterol secretion through hepatic ABCG5/G8 may exist as a novel mechanism by which GG consumption stimulates whole-body cholesterol loss and effectively reduces plasma cholesterol concentrations (Rideout 2007; Rideout and Fan 2008) .
Both targeted traditional molecular approaches and novel high-throughput technology may be employed to gain a more comprehensive understanding of how dietary soluble fi ber consumption regulates gene and protein express patterns. Unlike other dietary bioactive components that are thought to directly regulate the transcription of hepatic cholesterol-responsive genes (Mezei et al 2003) , dietary fi ber components are not absorbed from the gastrointestinal tract and therefore are generally thought to infl uence hepatic cholesterol homeostasis through secondary signaling systems and metabolites (Fernandez 1995) . Therefore, to fully delineate the molecular events by which soluble fi ber consumption modulates peripheral cholesterol metabolism, it will be critical to determine the molecular signals that are involved in mediating these secondary effects.
Conclusions
Although dietary fi ber may be considered a 'dinosaur' among other functional foods, it should not be perceived as extinct. The future relevance of functional fi ber-based foods will depend on the ability to integrate consumer health concerns with a comprehensive understanding of the health benefi ts and diseaseprevention potential of unique varieties of soluble fi bers. Due to the specifi c physical-chemical attributes that are associated with fi bers that originate from different plant sources and produced with alternative processing technologies, dietary fi bers are unique functional ingredients that have wide-ranging appeal in the functional food community. While the hypocholesterolemic effects associated with soluble fi ber consumption are clear, a comprehensive understanding of these effects, particularly at the molecular level, will require additional exploration. Advances in understanding the variable interindividual response to dietary soluble fi bers and the effect of fi ber consumption on expression patterns at the gene, protein and metabolite level will advance through application of traditional molecular tools and novel highthroughput technology. Detailed knowledge of the mechanisms by which different soluble fi bers reduce plasma cholesterol concentrations is paramount to developing novel fi ber-based "cocktails" and portfolio-type diets that target specifi c metabolic pathways to gain maximal cholesterol reductions.
